B.A. Schrock Wealth Management, Inc.’s AbbVie ABBV Stock Holding History

B.A. Schrock Wealth Management, Inc.’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.65M	Buy	+33,286	New	+$8.53M	3.16%	3

Other funds holding ABBV

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

B.A. Schrock Wealth Management, Inc.'s ABBV Position: Q3 2026 in Review

B.A. Schrock Wealth Management, Inc. opened a new position in AbbVie (ABBV) in Q3 2026: 33,286 shares worth $8.65M. The stake represents 3.16% of the portfolio and ranks #3 among its holdings.

652 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

B.A. Schrock Wealth Management, Inc. held 33,286 shares of AbbVie worth $8.65M as of Q3 2026.
AbbVie was a new B.A. Schrock Wealth Management, Inc. position in Q3 2026.
AbbVie made up 3.16% of B.A. Schrock Wealth Management, Inc.'s portfolio in Q3 2026, its #3 holding.
652 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on B.A. Schrock Wealth Management, Inc.'s 13F filing for Q3 2026, filed 15 Oct 2026.